Photo from wikipedia
Tixagevimab-cilgavimab is the only nonvaccine drug currently authorized in the United States for the prevention of COVID-19 infection in individuals who are moderately to severely immunocompromised or unable to receive… Click to show full abstract
Tixagevimab-cilgavimab is the only nonvaccine drug currently authorized in the United States for the prevention of COVID-19 infection in individuals who are moderately to severely immunocompromised or unable to receive COVI.
Keywords:
cilgavimab covid;
exposure prophylaxis;
tixagevimab cilgavimab;
cilgavimab;
covid pre;
pre exposure
Journal Title: Clinical journal of oncology nursing
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Clinical journal of oncology nursing
Year Published: 2022
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!